Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 1999

View Archived Issues

Intranasal morphine achieves plasma levels similar to intramuscular injection

Resolution presents nine papers at Society of Nuclear Medicine meeting

AxyS Pharmaceuticals enters combinatorial chemistry collaboration with Novalon

Immunex renews gene license with Digital Gene Technologies

J&J Medical and Integra LifeSciences announce marketing alliance for Integra Artificial Skin

Study results published for Atridox periodontal therapy

Phase II results reported for Novavax's Estrasorb

FDA clears Cutivate cream for treatment of atopic dermatitis in children

Interferon alfa for treatment of HPV successfully delivered without injection

Transgene initiates phase I trial of malignant melanoma product

Avant achieves milestone in rotavirus vaccine program with SB

Antiallergic agents in the pipeline at Asahi Chemical

Chimeric Therapies initiates pivotal trial evaluating proprietary method for allogeneic BMT

Pharsight's KADD expected to accelerate clinical drug development at AstraZeneca

Another series of factor Xa inhibitors patented by AxyS

Potent and selective arylpyrrolidine 5-HT1A ligands presented by Korean investigators

Insulin glargine: an improved treatment option for insulin-requiring diabetics

Inhaled insulin is comparable to s.c. insulin in terms of efficacy and safety

MENT increases sexual activity and may improve mood in hypogonadal men

Elcometrine implant provides safe and effective contraception in nursing women

Daclizumab may have applications in uveitis therapy

Bristol-Myers Squibb files for FDA approval of Taxol/Herceptin combination

AC-6 gene shows positive preclinical results in cardiomyopathy

Tipranavir is active against 90% of HIV strains with high resistance to protease inhibitors

Gliadel successfully completes mutual recognition procedure in 10 E.U. countries

Novel KAT inhibitors for age-related and perinatal cognition disorders

German pharmaceutical giant teams up with national biotech upstart in life science research

Novel beta3-adrenoceptor-selective antidiabetic candidates synthesized at Yamanouchi

Pierre Fabre profiles 5-HT1B/1D agonist at headache meeting in Barcelona

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...